×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Tscan Therapeutics Inc. (TCRX) NASDAQ

$6.76 (0.06) (-0.88%)

Market Cap: $294.39M

As of 02/23/24 04:00 PM EST. Market closed.

(TCRX)

Tscan Therapeutics Inc. (TCRX)
NASDAQ

$6.76
(0.06) (-0.88%)

Market Cap: $294.39M

As of 02/23/24 04:00 PM EST. Market closed.

Add to Portfolio

harnessing novel t cell systems to extend the promise of ... read more

harnessing novel t cell systems to extend the promise of immunotherapy read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
127
Address
.
PRICE CHART FOR TSCAN THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.53
Previous Close
$6.82
Days Range
$6.40 - $6.80
52 week range
$1.62 - $7.87
Volume
100,576
Avg. Volume (30 days)
163,792
Market Cap
$294.39M
Dividend Yield
-
P/E
(3.33)
Shares Outstanding
43,548,092
Open
$6.53
Previous Close
$6.82
Days Range
$6.40 - $6.80
52 week range
$1.62 - $7.87
Volume
100,576
Avg. Volume (30 days)
163,792
Market Cap
$294.39M
Dividend Yield
-
P/E
(3.33)
Shares Outstanding
43,548,092
FINANCIAL STATEMENTS FOR TSCAN THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TSCAN THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
BARBERICH TIMOTHY JDirectorDec 19, 2023 Buy$4.973171,57567,027Dec 21, 2023, 05:00 PM
BARBERICH TIMOTHY JDirectorDec 18, 2023 Buy$4.8928,830140,88166,710Dec 21, 2023, 05:00 PM
Klencke BarbaraDirectorDec 14, 2023 Buy$5.085,00025,40030,000Dec 18, 2023, 06:01 PM
BARBERICH TIMOTHY JDirectorJun 02, 2023 Buy$2.6337,88099,56437,880Jun 06, 2023, 07:53 PM
Lynx1 Capital Management LP10% OwnerMay 31, 2023 Sale$2.5225,40063,9535,240,000Jun 02, 2023, 05:35 PM
Silver Brian M.Chief Financial OfficerDec 27, 2022 Buy$1.502,8424,27629,727Dec 29, 2022, 02:34 PM
Silver Brian M.Chief Financial OfficerDec 28, 2022 Buy$1.563,1584,94132,885Dec 29, 2022, 02:34 PM
SOUTHWELL DAVID PChief Executive OfficerMay 18, 2022 Buy$3.5925,00089,821171,569May 20, 2022, 04:15 PM
BAKER BROS. ADVISORS LPDirectorMay 11, 2022 Buy$1.9925,86551,3502,528,583May 12, 2022, 04:41 PM
BAKER BROS. ADVISORS LPDirectorMay 10, 2022 Buy$1.881,333,9272,507,8042,505,600May 12, 2022, 04:41 PM
Silver Brian M.Chief Financial OfficerMar 24, 2022 Buy$3.4015,00050,98226,885Mar 28, 2022, 04:31 PM
SOUTHWELL DAVID PChief Executive OfficerDec 23, 2021 Option Exercise$1.9748,67095,880146,569Dec 27, 2021, 04:30 PM
ZDRAVESKI ZORANChief Legal OfficerSep 23, 2021 Buy$7.484,71635,2554,716Sep 27, 2021, 05:22 PM
Silver Brian M.Chief Financial OfficerSep 21, 2021 Buy$6.325,00031,58511,885Sep 22, 2021, 06:51 PM
MacBeath GavinChief Scientific OfficerSep 21, 2021 Buy$6.195735349,767Sep 22, 2021, 06:48 PM
MacBeath GavinChief Scientific OfficerSep 20, 2021 Buy$6.224,94330,74449,710Sep 22, 2021, 06:48 PM
Silver Brian M.Chief Financial OfficerSep 09, 2021 Buy$8.485,88549,9256,885Sep 13, 2021, 04:37 PM
SOUTHWELL DAVID PChief Executive OfficerSep 08, 2021 Buy$8.7311,00096,06697,899Sep 09, 2021, 04:43 PM
Desmarais WilliamChief Business OfficerAug 27, 2021 Buy$9.082,50022,7082,500Aug 31, 2021, 05:56 PM
Westphal Christoph H10% OwnerJul 20, 2021 Buy$15.00133,3331,999,9951,278,838Jul 22, 2021, 04:46 PM
BAKER BROS. ADVISORS LPDirectorJul 20, 2021 Buy$15.001,425,00021,375,0001,320,302Jul 22, 2021, 04:06 PM
Silver Brian M.Chief Financial OfficerJul 20, 2021 Buy$15.001,00015,0001,000Jul 22, 2021, 07:37 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
BARBERICH TIMOTHY JDirector12/19/20231,575
BARBERICH TIMOTHY JDirector12/18/2023140,881
Klencke BarbaraDirector12/14/202325,400
BARBERICH TIMOTHY JDirector06/02/202399,564
Lynx1 Capital Management LP10% Owner05/31/202363,953
Silver Brian M.Chief Financial Officer12/27/20224,276
Silver Brian M.Chief Financial Officer12/28/20224,941
SOUTHWELL DAVID PChief Executive Officer05/18/202289,821
BAKER BROS. ADVISORS LPDirector05/11/202251,350
BAKER BROS. ADVISORS LPDirector05/10/20222,507,804
Silver Brian M.Chief Financial Officer03/24/202250,982
SOUTHWELL DAVID PChief Executive Officer12/23/202195,880
ZDRAVESKI ZORANChief Legal Officer09/23/202135,255
Silver Brian M.Chief Financial Officer09/21/202131,585
MacBeath GavinChief Scientific Officer09/21/2021353
MacBeath GavinChief Scientific Officer09/20/202130,744
Silver Brian M.Chief Financial Officer09/09/202149,925
SOUTHWELL DAVID PChief Executive Officer09/08/202196,066
Desmarais WilliamChief Business Officer08/27/202122,708
Westphal Christoph H10% Owner07/20/20211,999,995
BAKER BROS. ADVISORS LPDirector07/20/202121,375,000
Silver Brian M.Chief Financial Officer07/20/202115,000
Load More Insider Transactions
FUNDS WITH A POSITION IN TSCAN THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ADAGE CAPITAL PARTNERS GP, L.L.C.3,900,0000.05%-2.5%Other
BAKER BROS. ADVISORS LP2,784,7920.18%No changeOther
BLACKROCK INC.1,671,7270.00025%-0.52%Other
GEODE CAPITAL MANAGEMENT, LLC391,6460.00024%27.18%Other
BALYASNY ASSET MANAGEMENT L.P.45,9860.0005%NewEvent Driven
RENAISSANCE TECHNOLOGIES LLC21,7000.0002%22.6%Other
BUYBACK ANNOUNCEMENT(S) FOR TSCAN THERAPEUTICS INC
LOADING...